Multimodal evaluation of 19F-BPA internalization in pancreatic cancer cells for boron capture and proton therapy potential applications

Sereti, 2018, Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: Emerging allies in the war on a devastating cancer?, J Proteomics, 188, 107, 10.1016/j.jprot.2018.01.012 Rawla, 2019, Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors, World J Oncol, 10, 10, 10.14740/wjon1166 Seshacharyulu, 2017, Biological determinants of radioresistance and their remediation in pancreatic cancer, Biochim Biophys Acta, Rev Cancer, 1868, 69, 10.1016/j.bbcan.2017.02.003 Dell’Oro, 2020, Clinical Limitations of Photon, Proton and Carbon Ion Therapy in Pancreatic Cancer, Cancers (Basel), 12, 163, 10.3390/cancers12010163 Barth, 2005, Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects, Clin Cancer Res, 11, 3987, 10.1158/1078-0432.CCR-05-0035 Moss, 2014, Critical review with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT), Appl Radiat Isotop, 88, 2, 10.1016/j.apradiso.2013.11.109 Barth, 2009, Boron neutron capture therapy at the crossroads: challenges and opportunities, Appl Radiat Isot, 67, S3, 10.1016/j.apradiso.2009.03.102 Savolainen, 2013, Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiences, Phys Med, 29, 233, 10.1016/j.ejmp.2012.04.008 Porcari P, Capuani S, Pastore FS. Novel Pharmacological and Magnetic Resonance Strategies to Enhance Boron Neutron Capture Therapy (BNCT) Efficacy in the Clinical Treatment of Malignant Glioma, in Management of CNS Tumors. 2011; 267. doi: 10.5772/24756. Barth, 2018, Boron delivery agents for neutron capture therapy of cancer, Cancer Commun, 38, 35, 10.1186/s40880-018-0299-7 Capuani, 2008, L-DOPA Preloading Increases the Uptake of Borophenylalanine in C6 Glioma Rat Model: A New Strategy to Improve BNCT Efficacy, Int J Radiat Oncol Biol Phys, 72, 562, 10.1016/j.ijrobp.2008.06.1493 Malouff, 2021, Boron Neutron Capture Therapy: A Review of Clinical Applications, Front Oncol, 11, 10.3389/fonc.2021.601820 Capuani, 2009, Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading, Appl Radiat Isot, 67, S34, 10.1016/j.apradiso.2009.03.017 Wongthai, 2015, Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATBo,+, LAT1 and LAT2, Cancer Sci, 106, 279, 10.1111/cas.12602 Nakagawa, 2003, Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams, J Neurooncol, 62, 87, 10.1007/BF02699936 Sköld, 2010, Boron Neutron Capture Therapy for glioblastoma multiforme: Advantage of prolonged infusion of BPA-f, Acta Neurol Scand, 122, 58, 10.1111/j.1600-0404.2009.01267.x Wang, 2014, Fractionated BNCT for locally recurrent head and neck cancer: experience from a phase I/II clinical trial at Tsing Hua Open-Pool Reactor, Appl Radiat Isot, 88, 23, 10.1016/j.apradiso.2013.11.134 Wang, 2018, Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor, Cancer Commun, 38, 37, 10.1186/s40880-018-0295-y Jung, 2016, Therapy region monitoring based on PET using 478keV single prompt gamma ray during BNCT: A Monte Carlo simulation study, Phys Med, 32, 562, 10.1016/j.ejmp.2016.02.010 Jung, 2017, Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a Monte Carlo study, Oncotarget, 8, 39774, 10.18632/oncotarget.15700 Cirrone, 2018, First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness, Sci Rep, 8, 10.1038/s41598-018-19258-5 Hanaoka, 2014, FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model, EJNMMI Res, 4, 10.1186/s13550-014-0070-2 Ishiwata, 2019, 4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research, Ann Nucl Med, 33, 223, 10.1007/s12149-019-01347-8 Tirotta, 2015, 19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications, Chem Rev, 115, 1106, 10.1021/cr500286d Porcari, 2009, In vivo 19F MR imaging and spectroscopy for the BNCT optimization, Appl Radiat Isot, 67, S365, 10.1016/j.apradiso.2009.03.065 Porcari, 2008, In vivo 19F MRI and 19F MRS of 19F-labelled boronophenylalanine–fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT), Phys Med Biol, 53, 6979, 10.1088/0031-9155/53/23/021 Wittig, 2008, Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT), Crit Rev Oncol Hematol, 68, 66, 10.1016/j.critrevonc.2008.03.004 Martano, 2015, Fast sampling method for mammalian cell metabolic analyses using liquid chromatography-mass spectrometry, Nat Protoc, 10, 1, 10.1038/nprot.2014.198 Johnson, 2016, Metabolomics: beyond biomarkers and towards mechanisms, Nat Rev Mol Cell Biol, 17, 451, 10.1038/nrm.2016.25 Kabalka, 2000, Synthesis of 4-borono-2-fluorophenylalanine, Org Prep Proced Int, 32, 290, 10.1080/00304940009355929 Ferrari, 2011, In Vitro and In Vivo Studies of Boron Neutron Capture Therapy: Boron Uptake/Washout and Cell Death, Radiat Res, 175, 452, 10.1667/RR2156.1 Bi, 2013, Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells, Anal Bioanal Chem, 405, 5279, 10.1007/s00216-013-6927-9 Luo, 2018, Development of a simple and efficient method of harvesting and lysing adherent mammalian cells for chemical isotope labeling LC-MS-based cellular metabolomics, Anal Chim Acta, 1037, 97, 10.1016/j.aca.2017.11.054 Postuma, 2016, An improved neutron autoradiography set-up for 10B concentration measurements in biological samples, Rep Pract Oncol Radiother, 21, 123, 10.1016/j.rpor.2015.10.006 Bortolussi, 2011, Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours, Appl Radiat Isot, 69, 394, 10.1016/j.apradiso.2010.11.018 Portu, 2015, Inter-comparison of boron concentration measurements at INFN-University of Pavia (Italy) and CNEA (Argentina), Appl Radiat Isot, 105, 35, 10.1016/j.apradiso.2015.07.022 Kur-Kowalska, 2014, The study of phenylboronic acid optical properties towards creation of a glucose sensor, Biotechnol Food Sci, 78, 101 Panov, 2000, Uptake and washout of borocaptate sodium and borono-phenylalanine in cultured melanoma cells: a multi-nuclear NMR study, Radiat Res, 154, 104, 10.1667/0033-7587(2000)154[0104:UAWOBS]2.0.CO;2 Porcari, 2006, Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields, Phys Med Biol, 51, 3141, 10.1088/0031-9155/51/12/010 Vähätalo, 1998, Trace impurities identified by high performance liquid chromatography/electrospray mass spectrometry in two different synthetic batches of 4–boronophenylalanne, Rapid Commun Mass Spectrom, 12, 1118, 10.1002/(SICI)1097-0231(19980831)12:16<1118::AID-RCM289>3.0.CO;2-1 Gibson, 2002, Electrospray ionization mass spectrometry coupled to reversed-phase ion-pair high-performance liquid chromatography for quantitation of sodium borocaptate and application to pharmacokinetic analysis, Anal Chem, 74, 2394, 10.1021/ac0112723 Mauri, 2003, New approach for the detection of BSH and its metabolites using capillary electrophoresis and electrospray ionization mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed, Life Sci, 788, 9 Shichi, 2019, Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture, Sci Rep, 9, 10.1038/s41598-019-47416-w Gradiz, 2016, MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors, Sci Rep, 6, 21648, 10.1038/srep21648 Watanabe, 2012, Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics, J Mol Biomark Diagn, 3, S3, 10.4172/2155-9929.S3-002 Holzgrabe, 2010, Quantitative NMR spectroscopy in pharmaceutical Applications, Prog Nucl Magn Reson Spectrosc, 57, 229, 10.1016/j.pnmrs.2010.05.001